# FDA Inspection 1042326 - Operative Innovations, LLC - February 13, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/operative-innovations-llc/8c4fd547-e865-401d-921d-3dd84bf174aa
Source feed: FDA_Inspections

> FDA Inspection 1042326 for Operative Innovations, LLC on February 13, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1042326
- Company Name: Operative Innovations, LLC
- Inspection Date: 2018-02-13
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1293436 - 2025-09-29](https://www.globalkeysolutions.net/records/fda_inspections/operative-innovations-llc/74df9f1e-2446-4a5f-9c22-6469d40acce9)
- [FDA Inspection 1293436 - 2025-09-29](https://www.globalkeysolutions.net/records/fda_inspections/operative-innovations-llc/dedb9544-6347-4ea6-89c2-3401d5e42139)
- [FDA Inspection 872843 - 2014-04-01](https://www.globalkeysolutions.net/records/fda_inspections/operative-innovations-llc/b36a1c3f-5658-42f6-8758-3ce29b509241)

Company: https://www.globalkeysolutions.net/companies/operative-innovations-llc/c3dca4cd-ebc1-456a-adae-3deb5ad8d5ec

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d